View Cart  

Contaminated Heparin Remains Key GMP Concern for FDA

A A
The contaminated heparin crisis from years back that affected device- and drugmakers “could still be happening” and the FDA continues to focus some of its limited resources on keeping the fake anticoagulant out of the U.S. drug supply.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00